tirzepatide and kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide improves kidney outcomes in

11.3 Consensus of expert panel Seventy percent of experts agreed that the role of NAC in asthma is ambiguous, though 60% felt it may reduce air pollutioninduced hyperresponsiveness

The drug was originally approved for adults with obesity in June 2021

10.1177/1533317515602548 13 BaloyannisS

Synapse adds the synaptogenesis layer that no other compound on the menu provides

Additionally, the drugs have been called anti-obesity medications (AOMs) by some researchers who criticize the drugs for the possibility of severe side effects, the lack of research into long-term use and the possibility of triggering eating disorders in some patients